Fiche de révision : Cystic Fibrosis: Pathophysiology and Management

📋 Course Outline

1. Core principles of CF
2. CF pathophysiology
3. CF diagnosis methods
4. CFTR mutations
5. CF management and treatments
6. CF lung disease
7. CF pancreatic and gut disease
8. CF related diabetes
9. CF liver and reproductive issues

📖 1. Core principles of CF

🔑 Key Concepts & Definitions

Cystic Fibrosis (CF) is the most common genetic disease among white European populations, affecting 1 in 2500 babies born in the UK. CF results from defects in the CF transmembrane conductance regulator (CFTR) gene, which codes for a chloride channel expressed in epithelial cells of multiple organs, including the lungs and pancreas. CFTR is a multifunctional protein that regulates ion flux across cell membranes, with over 1000 mutations described, 1085 of which are CF-causing. Autosomal recessive genetic disease means that a person must inherit two defective copies of the CFTR gene to develop CF, while carriers have one normal and one mutated gene. Carrier status indicates an individual with one mutated CFTR gene, approximately 1 in 25 people in the UK, most unaffected. The median age of diagnosis is around 23 days, largely due to newborn screening programs.

📝 Essential Points

CF is the most prevalent genetic disorder among white Europeans, affecting 1 in 2500 UK infants. It stems from mutations in the CFTR gene, which encodes a chloride channel vital for maintaining ion balance in epithelial cells across various organs. The disease follows an autosomal recessive inheritance pattern, with about 1 in 25 UK individuals being carriers, typically unaffected. The median age of diagnosis is approximately 23 days, facilitated by newborn screening initiatives such as the Guthrie test, which detects elevated immunoreactive trypsinogen (IRT) and CFTR mutations. Understanding CF as a multisystem disorder rooted in CFTR dysfunction and its inheritance pattern is fundamental to grasping its clinical presentation and management.

📖 2. CF pathophysiology

🔑 Key Concepts & Definitions

CFTR protein structure and function: CFTR is a gated anion channel that regulates ion flux across epithelial cell membranes, controlling the movement of chloride and other ions. Its proper function maintains the balance of ions and water on epithelial surfaces.

Ion channel regulation: The activity of CFTR as a gated channel is essential for ion transport regulation. When functioning correctly, it facilitates chloride ion movement, which influences fluid secretion and absorption in epithelial tissues.

Mucus viscosity: The regulation of ion transport by CFTR impacts the hydration of mucus. Defective CFTR results in decreased ion and water movement, leading to thick, sticky mucus that is difficult to clear.

Ciliary dysfunction: Loss of proper mucus hydration due to CFTR malfunction impairs ciliary movement. This ciliary dysfunction hampers mucociliary clearance, allowing mucus to accumulate and obstruct airways.

Airway surface liquid depletion: When CFTR is defective, decreased chloride and water secretion cause depletion of airway surface liquid. This dehydration results in thick mucus and compromised mucociliary function.

📝 Essential Points

CFTR is a gated anion channel that regulates ion flux across epithelial cell membranes, primarily controlling chloride movement. Its proper function ensures adequate hydration of mucus on epithelial surfaces.

Defective CFTR leads to decreased airway surface liquid, causing mucus to become thick and sticky. This abnormal mucus impairs the normal clearance mechanisms of the respiratory tract.

Loss of ciliary function results from the thickened mucus, leading to impaired mucociliary clearance. Mucus plugging occurs, obstructing airways and trapping pathogens.

The presence of thick mucus predisposes the lungs to chronic infections and inflammation. This persistent infection cycle drives progressive organ damage, especially in the respiratory system.

💡 Key Takeaway

The core of CF pathophysiology lies in defective ion transport due to faulty CFTR, which causes thick mucus and impaired clearance, ultimately leading to organ damage through recurrent infections and inflammation.

📖 3. CF diagnosis methods

🔑 Key Concepts & Definitions

• Newborn screening (NBS): A process that uses biochemical and genetic tests to identify cystic fibrosis (CF) early in newborns, enabling prompt intervention.

• Immunoreactive trypsinogen (IRT) test: A biochemical screening test measuring IRT levels in blood; elevated levels suggest possible CF, prompting further testing.

• Sweat chloride test: The gold standard diagnostic procedure for CF, involving pilocarpine iontophoresis to induce sweat collection; chloride concentration >60 mmol/L confirms diagnosis.

• CFTR mutation analysis: Genetic testing that identifies mutations in the CFTR gene; helps confirm CF diagnosis and guide treatment decisions.

• Faecal elastase test: A functional assessment measuring elastase enzyme in stool; low levels indicate pancreatic exocrine insufficiency associated with CF.

📝 Essential Points

Newborn screening employs IRT measurement and mutation analysis to identify CF early, facilitating timely management. The sweat chloride test, performed via pilocarpine iontophoresis, is considered the gold standard diagnostic test; a chloride level exceeding 60 mmol/L confirms CF. CFTR mutation analysis assists in confirming the diagnosis and provides genetic information that can guide treatment options. The faecal elastase test evaluates pancreatic exocrine function, with low elastase levels indicating pancreatic insufficiency, a common complication in CF patients.

💡 Key Takeaway

Diagnosis of CF relies on a combination of biochemical screening (IRT), sweat testing, genetic analysis, and functional assessment (faecal elastase) to accurately confirm the condition and inform management strategies.

📖 4. CFTR mutations

🔑 Key Concepts & Definitions

F508del mutation: The most common mutation in Caucasians, involving the deletion of phenylalanine at position 508 of the CFTR protein, leading to defective protein processing.

Mutation classification: A system that categorizes CFTR mutations based on their effects on protein function, though the type of mutation does not correlate well with lung function severity.

G551D mutation: A specific CFTR mutation that is a target for CFTR potentiator therapy, such as ivacaftor, which enhances channel activity.

Nonsense mutations: Mutations that introduce premature stop codons, resulting in truncated, non-functional CFTR proteins.

Genotype-phenotype correlation: The relationship between specific CFTR mutations (genotype) and the clinical presentation or severity of cystic fibrosis (phenotype), which is often weak in CF.

📝 Essential Points

Over 1000 CFTR mutations have been described, with 1085 identified as CF-causing. The F508del mutation is the most prevalent among Caucasians, characterized by the deletion of phenylalanine at position 508. Despite the diversity of mutations, the mutation type does not correlate well with the severity of lung function impairment. The G551D mutation is notable because it is a target for mutation-specific therapy, such as CFTR potentiators like ivacaftor. Additionally, mutations include nonsense types, which lead to early termination of protein synthesis, and contribute to the overall mutation spectrum. Understanding the broad mutation landscape underscores the importance of personalized approaches, as diverse mutations influence disease expression and treatment options.

💡 Key Takeaway

Diverse CFTR mutations underlie cystic fibrosis, affecting disease manifestation and enabling the development of mutation-specific therapies, although mutation type alone does not predict disease severity.

📖 5. CF management and treatments

🔑 Key Concepts & Definitions

Multidisciplinary team (MDT): A collaborative group of healthcare professionals—including doctors, nurses, physiotherapists, dietitians, and pharmacists—who work together to manage cystic fibrosis (CF) care effectively.

Physiotherapy: A daily essential treatment in CF management involving techniques to clear mucus from the lungs, helping maintain lung function and prevent infections.

Pancreatic enzyme replacement therapy (PERT): A critical treatment for managing pancreatic insufficiency in CF, involving the administration of enzymes to aid digestion and nutrient absorption.

CFTR modulators: Targeted therapies such as ivacaftor and lumacaftor that improve CFTR protein function, leading to better clinical outcomes in CF patients.

Antibiotic therapy: The use of antibiotics prophylactically and acutely to prevent and treat lung infections common in CF.

📝 Essential Points

Management of CF requires a multidisciplinary team including doctors, nurses, physiotherapists, dietitians, and pharmacists. This team collaborates to deliver comprehensive care tailored to individual patient needs.

Physiotherapy and nutrition are daily essential treatments. Physiotherapy helps clear mucus to maintain lung function, while nutrition support ensures proper growth and development.

Pancreatic enzyme replacement therapy (PERT) is vital for managing pancreatic insufficiency. It aids digestion and nutrient absorption, addressing one of the core issues in CF.

CFTR modulators, such as ivacaftor and lumacaftor, are therapies that improve CFTR protein function. They enhance clinical outcomes by targeting the underlying defect in CF.

Antibiotic therapy is used both prophylactically and acutely. It manages lung infections, which are common and serious complications in CF patients.

💡 Key Takeaway

Effective CF care integrates multidisciplinary approaches combining symptom management and targeted therapies to optimize health outcomes.

📖 6. CF lung disease

🔑 Key Concepts & Definitions

Mucus plugging: The accumulation of thick, sticky mucus within the airways that obstructs airflow and impairs clearance, leading to airway blockage and infection.

Chronic infection: Persistent bacterial colonization of the airways, resulting in ongoing inflammation and tissue damage over time.

Pseudomonas aeruginosa colonization: The frequent colonization of the respiratory tract by Pseudomonas aeruginosa bacteria, which often requires targeted antibiotic therapy to manage.

Airway inflammation: The immune response characterized by swelling, redness, and infiltration of inflammatory cells in the airway walls, contributing to tissue damage and lung function decline.

Lung function decline: The progressive loss of respiratory capacity, often measured by spirometry, which correlates strongly with disease severity and survival.

📝 Essential Points

Approximately 97% of CF deaths are due to pulmonary causes, emphasizing the centrality of lung disease in CF morbidity and mortality. Thick mucus and impaired clearance mechanisms lead to the development of chronic bacterial infections and persistent airway inflammation. These processes cause tissue damage and contribute to the decline in lung function over time. Pseudomonas aeruginosa colonization is common in CF patients and necessitates targeted antibiotic therapy to control infection and reduce inflammation. Lung function and survival are strongly linked to nutritional status, highlighting the importance of comprehensive management to preserve respiratory health.

💡 Key Takeaway

Lung disease is the primary driver of morbidity and mortality in CF, driven by mucus obstruction and infection, which lead to airway inflammation and progressive lung function decline.

📖 7. CF pancreatic and gut disease

🔑 Key Concepts & Definitions

Pancreatic exocrine insufficiency: A condition where the pancreas produces insufficient digestive enzymes, leading to malabsorption and poor growth. Approximately 85% of CF patients experience this, resulting in difficulty digesting fats and other nutrients.

Steatorrhea: The presence of excess fat in stool, often greasy, bulky, and foul-smelling. It is a common gastrointestinal symptom in CF patients with pancreatic exocrine insufficiency, indicating fat malabsorption.

Distal Intestinal Obstruction Syndrome (DIOS): A gastrointestinal complication affecting 10-20% of CF patients, characterized by blockage in the distal intestine. It is typically treated with laxatives to relieve obstruction.

Malabsorption: Impaired absorption of nutrients from the gastrointestinal tract, often due to pancreatic exocrine insufficiency in CF. It leads to deficiencies in essential nutrients and poor growth.

Fat soluble vitamin deficiency: Deficiency of vitamins A, D, E, and K caused by malabsorption of fats. CF patients with pancreatic insufficiency are at risk and require supplementation to prevent deficiency-related complications.

📝 Essential Points

About 85% of CF patients have pancreatic exocrine insufficiency, which causes malabsorption and poor growth. Gastrointestinal symptoms such as steatorrhea and abdominal pain are common. DIOS affects 10-20% of patients and is managed with laxatives. Malabsorption from pancreatic insufficiency leads to deficiencies in fat-soluble vitamins A, D, E, and K, necessitating supplementation to prevent deficiencies.

💡 Key Takeaway

Pancreatic and gastrointestinal complications in CF significantly impair nutrition and growth, with malabsorption and related issues requiring targeted management to prevent long-term deficiencies and improve patient outcomes.

📖 8. CF related diabetes

🔑 Key Concepts & Definitions

CF-related diabetes (CFRD) is a form of diabetes that results from progressive pancreatic damage caused by cystic fibrosis, leading to insulin deficiency. It combines features of both type 1 and type 2 diabetes but is distinct in its pathophysiology and management.

Insulin deficiency in CFRD arises due to pancreatic damage, impairing insulin production. This deficiency causes elevated blood glucose levels, requiring insulin therapy despite milder symptoms compared to typical diabetes.

Oral glucose tolerance test (OGTT) is a diagnostic tool used to detect CFRD. It involves measuring blood glucose levels after administering a glucose load, helping identify insidious onset cases that may not be evident through symptoms alone.

Hypercaloric diet refers to a high-calorie nutritional intake essential in CF management. Despite the presence of diabetes, maintaining this diet is crucial for growth and energy needs, even though it requires careful balancing with glucose control.

Insidious onset describes the gradual development of CFRD, often without overt symptoms. It is typically detected through OGTT or home glucose monitoring rather than clinical signs, emphasizing the importance of routine screening.

📝 Essential Points

CFRD results from progressive pancreatic damage that causes insulin deficiency. Its onset is often insidious, meaning it develops gradually and may go unnoticed without specific testing. Detection relies on OGTT or home glucose monitoring, as symptoms tend to be milder than in typical diabetes but still necessitate insulin therapy. Maintaining a hypercaloric diet remains vital for CF patients, despite the need for glucose management, to support growth and overall health.

💡 Key Takeaway

CFRD is a unique diabetes form in CF that requires tailored detection through routine screening and careful management to balance insulin therapy with the nutritional needs of a hypercaloric diet.

📖 9. CF liver and reproductive issues

🔑 Key Concepts & Definitions

• CF-related liver disease: Liver complications in CF, including cirrhosis and portal hypertension, are common multisystem manifestations that impact survival and quality of life.

• Cholestasis: A condition causing impaired bile flow, leading to prolonged jaundice in infants with CF.

• Portal hypertension: Elevated blood pressure in the portal venous system, often resulting from CF-related cirrhosis, and a significant cause of liver-related morbidity.

• Absent vas deferens: A congenital absence of the vas deferens in males with CF, leading to infertility despite normal spermatogenesis.

• Infertility in CF: Females with CF have reduced fertility primarily due to poor nutrition and thick cervical mucus, affecting conception.

📝 Essential Points

• Liver disease is the second most frequent cause of death in CF, including cirrhosis and portal hypertension.

• Cholestasis causes prolonged jaundice in infants with CF, indicating impaired bile flow.

• 98% of CF males have absent vas deferens, which causes infertility despite normal sperm production.

• CF females experience reduced fertility mainly due to poor nutritional status and thick cervical mucus, which hinder conception.

💡 Key Takeaway

Liver complications and reproductive tract abnormalities are critical multisystem issues in CF that significantly influence survival and quality of life.

📊 Synthesis Tables

⚠️ Common Pitfalls & Confusions

1. Confusing carrier status with having CF disease—carriers have one mutated gene but are unaffected.
2. Assuming all CFTR mutations have the same clinical severity—mutation effects vary widely.
3. Overreliance on the sweat chloride test alone without genetic confirmation.
4. Misinterpreting the mutation classification system as directly predicting disease severity.
5. Believing that CF only affects the lungs—other organs like pancreas, liver, and reproductive system are involved.
6. Assuming CFTR modulators are effective for all mutations—only certain mutations respond.
7. Confusing cystic fibrosis-related diabetes with type 1 or type 2 diabetes—distinct pathophysiology.
8. Underestimating the importance of a multidisciplinary approach in management.

✅ Exam Checklist

• Know that cystic fibrosis is the most common genetic disorder among white Europeans and its prevalence in the UK.
• Understand that CF results from mutations in the CFTR gene encoding a chloride channel expressed in multiple organs.
• Describe the autosomal recessive inheritance pattern and carrier frequency (~1 in 25 in the UK).
• Recognize that the median age of diagnosis is around 23 days, aided by newborn screening programs like IRT testing.
• Explain how defective CFTR causes decreased chloride and water transport, leading to thick mucus and impaired mucociliary clearance.
• Identify the main diagnostic methods: newborn screening (IRT), sweat chloride test (>60 mmol/L), CFTR mutation analysis, faecal elastase test.
• Know that over 1000 mutations exist; F508del is most common; mutation classification does not strongly predict phenotype.
• Be familiar with management strategies including multidisciplinary care, airway clearance techniques, antibiotics, pancreatic enzyme replacement therapy, and CFTR modulators like ivacaftor.
• Understand that lung disease involves mucus plugging, recurrent infections (especially Pseudomonas aeruginosa), bronchiectasis, and progressive decline.
• Recognize pancreatic exocrine insufficiency causes malabsorption and failure to thrive; meconium ileus may be an early sign.
• Know that CF-related diabetes results from pancreatic damage and requires insulin therapy.
• Be aware of liver disease due to biliary cirrhosis and reproductive issues such as male infertility from CBAVD and preserved female fertility with potential mucus thickening.
• Know authors & references: none explicitly specified in content.